Table 4.
Spearman’s correlation between changes (three months-baseline) in apolipoproteins and body compositions (both sexes, N=34), P value is in parentheses
| Apo A2 | Apo C2 | Apo C3 | Apo E | Insulin | A1c % | FPG mg/dL | tchol | HDLc | LDLc | Chol/hdlr | BMI | BWT | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apo A1 | .559b (.001) | .216 (.219) | .506b (.022) | .392a (.022) | .105 (.553) | .138 (.438) | −.113 (.524) | .091 (.610) | .289 (.098) | .004 (.981) | −.009 (.958) | .016 (.929) | −.042 (.811) |
| Apo A2 | 1.000 | .449b (.008) | .523b (.001) | .523b (.002) | −.130 (.462) | .055 (.757) | .022 (.902) | .105 (.555) | .236 (.180) | .113 (.524) | .020 (.911) | −.039 (.829) | −.123 (.489) |
| Apo C2 | 1.000 | .683b (<.001) | .632b (<.001) | .268 (.125) | .068 (.701) | −.319 (.066) | .530b (.001) | .086 (.630) | .344a (.046) | .563b (.001) | .045 (.801) | −.073 (.683) | |
| Apo C3 | 1.000 | .760b (<.001) | −.177 (.318) | .405a (.017) | .023 (.896) | .635b (<.001) | .233 (.185) | .366a (.033) | .487b (.004) | .057 (.749) | −.009 (.960) | ||
| Apo E | 1.000 | .103 (.561) | .313 (.072) | .054 (.763) | .746b (<.001) | .151 (.395) | .608b (<.001) | .638b (<.001) | .079 (.658) | .046 (.796) | |||
| Insulin | 1.000 | −.010 (.956) | .041 (.817) | −.198 (.262) | −.126 (.479) | −.285 (.103) | −.067 (.707) | −.026 (.883) | .055 (.756) | ||||
| A1c % | 1.000 | .563b (.001) | .391a (.022) | .241 (.170) | .370a (.031) | .196 (.266) | .253 (.149) | .334 .054 |
|||||
| FPG | 1.000 | .054 (.760) | .174 (.324) | .244 (.165) | −.124 (.484) | .248 (.158) | .217 (.218) | ||||||
| tchol | 1.000 | .189 (.284) | .847b (<.001) | .833b (<.001) | .043 (.811) | .079 .659 |
|||||||
| HDLc | 1.000 | .249 (.155) | −.257 (.143) | .039 (.827) | −.088 (.619) | ||||||||
| LDLc | 1.000 | .674b (<.001) | .103 (.562) | .089 (.619) | |||||||||
| Chol/hdlr | 1.000 | .054 (.762) | .077 (.663) | ||||||||||
| BMI | 1.000 | .732b (<.001) |
a
P<.05.
b
P<.005.